TRULIEVE CANNABIS CORP (TCNNF) earnings
TCNNF earnings moved a median of +1.56% by the close. Quarterly and annual TCNNF reports and results, each read against the price at its own news timestamp. Back to the TCNNF overview →
27 measured TCNNF earnings events.
Where these TCNNF earnings landedvs 27 measured TCNNF earnings reactions
| Middle 50% of TCNNF earnings reactions | -2.54% to +3.08% |
|---|---|
| Median reaction (to close) | +1.56% |
| Measured reactions | 27 |
Point-in-time · zero look-ahead
Half of the 27 TCNNF earnings events with a measured close landed between -2.54% and +3.08%; 56% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Trulieve Cannabis Corp. For: Mar 31 | SEC filing · Form 10-Q | -0.20% | -5.98% | |
| Trulieve Reports Profitable First Quarter 2026 Results Bolstered by Margins and Cash Flow Generation | Press release | -0.20% | -5.98% | |
| Trulieve Cannabis Corp. to Hold First Quarter 2026 Results Conference Call on May 7, 2026 | Press release | -1.40% | -5.35% | |
| Form 10-K Trulieve Cannabis Corp. For: Dec 31 | SEC filing · Form 10-K | -0.29% | +3.17% | |
| Form 10-Q Trulieve Cannabis Corp. For: Sep 30 | SEC filing · Form 10-Q | +4.13% | +2.58% | |
| Trulieve Reports Third Quarter 2025 Results Demonstrating Operational Discipline and Cash Flow Strength | Press release | +4.13% | +2.58% | |
| Trulieve Cannabis Corp. to Hold Third Quarter 2025 Results Conference Call on November 5, 2025 | Press release | -1.10% | +7.26% | |
| Form 10-Q Trulieve Cannabis Corp. For: Jun 30 | SEC filing · Form 10-Q | +4.88% | +1.93% | |
| Trulieve Reports Second Quarter 2025 Results Highlighting Progress on 2025 Plan | Press release | +4.88% | +1.93% | |
| Trulieve Cannabis Corp. to Hold Second Quarter 2025 Results Conference Call on August 6, 2025 | Press release | -0.92% | +3.23% | |
| Form 10-Q Trulieve Cannabis Corp. For: Mar 31 | SEC filing · Form 10-Q | +1.11% | -2.46% | |
| Trulieve Reports First Quarter 2025 Results Demonstrating Core Business Strength | Press release | +1.11% | -2.46% | |
| Trulieve Cannabis Corp. to Hold First Quarter 2025 Results Conference Call on May 7, 2025 | Press release | -3.43% | -5.68% | |
| Form 10-K Trulieve Cannabis Corp. For: Dec 31 | SEC filing · Form 10-K | +2.79% | +5.01% | |
| Form 10-Q Trulieve Cannabis Corp. For: Sep 30 | SEC filing · Form 10-Q | -3.29% | -8.98% | |
| Trulieve Reports Third Quarter 2024 Results Ahead of Florida Adult-Use Vote | Press release | -3.29% | -8.98% | |
| Trulieve Cannabis Corp. to Hold Third Quarter 2024 Results Conference Call on November 5, 2024 | Press release | +1.67% | +2.99% | |
| Form 10-Q Trulieve Cannabis Corp. For: Jun 30 | SEC filing · Form 10-Q | +2.38% | +10.07% | |
| Trulieve Reports Second Quarter 2024 Results Exceeding Quarterly Guidance | Press release | +2.38% | +10.07% | |
| Trulieve Cannabis Corp. to Hold Second Quarter 2024 Results Conference Call on August 6, 2024 | Press release | +0.54% | -1.40% | |
| Form 10-Q Trulieve Cannabis Corp. For: Mar 31 | SEC filing · Form 10-Q | +4.49% | +1.56% | |
| Trulieve Reports First Quarter 2024 Results Demonstrating Core Business Strength and Cash Generation | Press release | +4.49% | +1.56% | |
| Trulieve Cannabis Corp. to Hold First Quarter 2024 Results Conference Call on May 9, 2024 | Press release | -0.25% | +3.45% | |
| Form 10-K Trulieve Cannabis Corp. For: Dec 31 | SEC filing · Form 10-K | +3.62% | -2.62% | |
| Form 10-Q Trulieve Cannabis Corp. For: Sep 30 | SEC filing · Form 10-Q | +0.80% | -0.40% | |
| Trulieve Reports Third Quarter 2023 Results Delivering Significant Cash Generation | Press release | +0.80% | -0.40% | |
| Trulieve Cannabis Corp. to Hold Third Quarter 2023 Results Conference Call on November 9, 2023 | Press release | -0.20% | +1.83% |
Keep exploring
More TCNNF: analyst actions → · SEC filings → · TCNNF overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| SCYNEXIS, Inc. (SCYX) | 431 | 0.00% | 41% |
| LeMaitre Vascular, Inc. (LMAT) | 430 | +0.05% | 54% |
| Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares (KNSA) | 427 | -0.21% | 39% |
| Veracyte, Inc. (VCYT) | 427 | -0.15% | 46% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.